360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Cancer stem cell

Type: Keyphrase

Name: Cancer stem cell

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Glencore International Plc

Two Curtis Transactions Honored at International M&A Advisor Awards

Two Curtis Transactions were honored at the 5th Annual International M&A Advisor Awards, which recognizes the leading cross-border transactions, restructurings and deal financings globally.The $6.1 Billion Acquisition of Viterra by Glencore was chosen ... [Published Curtis - May 16 2013]

Entities: Bionomics Limited, Mergers & Acquisitions, Glencore International Plc

First reported May 10 2013 - Updated May 10 2013 - 1 reports

New Stem Cells Study Findings Have Been Reported by Researchers at University Medical Center

Stem Cell Research2013 MAY 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Stem Cell Research are discussed in a new report. According to news reporting originating in Mannheim, Germany, by NewsRx journalists, ... [Published NewsRX - May 10 2013]

Entities: Cancer stem cell, Stem Cell, Stem Cell Research, Mannheim, Tumor

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Verastem Inc

Verastem to Present at Upcoming Conferences

Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the management team will be presenting at several upcoming conferences. The presentation ... [Published Reuters - May 08 2013]

Entities: Verastem Inc, Cancer, Stem Cell

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Research Innovation Fund awards first projects

Seven grants totalling nearly half a million pounds have been awarded as part of Pancreatic Cancer UK’s first round of the Research Innovation Fund.The fund aims to boost new ideas and approaches, including those successful in other areas of cancer, to ... [Published National Health Executive - May 07 2013]

Entities: Pancreatic Cancer, Invention, Advisory Board, United Kingdom

First reported May 04 2013 - Updated May 04 2013 - 1 reports

New Findings from Roswell Park Cancer Institute in the Area of Stem Cells Reported

Stem Cell Research2013 MAY 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Stem Cell Research have been presented. According to news originating from Buffalo, New York, by NewsRx editors, the research stated, "This ... [Published NewsRX - May 04 2013]

Entities: Roswell Park Cancer Institute, Stem Cell, Stem Cell Research

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Friday Science Review: May 3, 2013

The use of oncolytic viruses is becoming an increasingly attractive avenue for the treatment of cancer, because these viruses are able to destroy tumor cells and also generate immune-responses directed at those same tumor cells. Using human viruses for ... [Published The Cross-Border Biotech Blog - May 03 2013]

Entities: Tumor, Virus, Stem Cell

First reported May 03 2013 - Updated May 03 2013 - 1 reports

National Cancer Institute

National Cancer Institute at Frederick Describes Findings in Stem Cells

Stem Cell Research2013 MAY 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Stem Cell Research. According to news originating from Frederick, Maryland, by NewsRx correspondents, research stated, ... [Published NewsRX - May 03 2013]

Entities: National Cancer Institute, Stem Cell, Stem Cell Research

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade

by Su-Feng Chen, Yaoh-Shiang Lin, Shu-Wen Jao, Yun-Ching Chang, Chia-Lin Liu, Yu-Ju Lin, Shin NiehBackgroundMetastasis occurs in a series of discrete steps involving invasion, angiogenesis, lymphovascular space permeation, and establishment of secondary ... [Published Elites TV - May 02 2013]

Entities: adenocarcinoma, pleural effusion, Metastatic

First reported Apr 23 2013 - Updated Apr 23 2013 - 3 reports

Lonza Makes Bionomics Clinical Candidate

Related Searches: Clinical Trial Materials • Preclinical • contractpharma.com • Biologics, Proteins, Vaccines •Related Breaking NewsLonza has begun manufacturing activities for Bionomics Limited's lead candidate, BNC101, following completion of key preclinical ... [Published Contract Pharma - Apr 23 2013]

Entities: Bionomics Limited, Lonza Group AG, Clinical trials, Cancer stem cell

First reported Apr 18 2013 - Updated Apr 19 2013 - 2 reports

STEM CELL THERAPEUTICS CORP.: Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program

, the technology licensed by SCT is based on Dr. Aaron Schimmer's discovery that an FDA-approved antibiotic, tigecycline, selectively targets leukemia cells and leukemic stem cells by inhibiting mitochondrial protein synthesis and thus shutting down the ... [Published 4 Traders - Apr 19 2013]

Entities: Stem Cell Therapeutics Corporation, Cancer stem cell, Stem Cell, Cancer, Chemotherapy

First reported Apr 17 2013 - Updated Apr 17 2013 - 5 reports

Stem Cell Therapeutics Licenses Exclusive Rights to Clinical. . .

Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell ProgramCorporate refocusing mission completedMarketwire - CanadaTORONTO, ONTARIO--(Marketwired - April 17, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a biopharmaceutical ... [Published Equities.com - Apr 17 2013]

Entities: Stem Cell Therapeutics Corporation, Cancer stem cell, Stem Cell, Cancer

First reported Apr 15 2013 - Updated Apr 15 2013 - 2 reports

Novel Surface Marker Helps Scientists "Fish Out" Mammary Gland Stem Cells, Cold Spring Harbor Laboratory Study

Stem cells are different from all other cells in our body because they retain the remarkable genetic plasticity to self-renew indefinitely as well as develop into cell types with more specialized functions. However, this remarkable self-renewal capacity ... [Published BioSpace - Apr 15 2013]

Entities: Stem Cell, Cold Spring Harbor Laboratory, laboratory study

Quotes

2. Chatterjee A , et al. "Regulation of p53 Member Isoform DNp63a by the Nuclear Factor-kB Targeting Kinase IkB Kinase b,” Cancer Research, Vol. 70, Iss. 4, February 15, 2010: p1419–1429."

Big Data Unveils Exciting Head and Neck Cancer Targets [Published Bioscience Technology Online - 3 hours ago]

Our news journalists obtained a quote from the research, "Here we show, for the first time, that LGR5 is expressed in normal pancreas, exclusively in the islets of Langerhans and it is co-localized, surprisingly, with Nanog and insulin in clusters of beta cells. In cancerous pancreas Nanog and LGR5 are expressed in the remaining islets and in all ductal cancer cells. We observed insulin staining among the ductal cancer cells, but not in metastases. This indicates that the islet's beta cells, expressing LGR5 and Nanog markers are the initiating cells of pancreas cancer, which migrated from the islets to form the ductal cancerous tissue, probably after mutation and de-differentiation."

Findings from A. Amsterdam and Co-Authors Provides New Data about Stem Cells [Published NewsRX - May 17 2013]

...internationally and we undertake this step as part of a deliberate and long-term strategy," commented Stem Cell Therapeutics Chairman David Allan. "The admission to the OTCQX is one of several undertakings that the company committed to complete this year. The acquisition of Trillium, the in-licensing of the tigecycline program and the recent completion of dosing in the interstitial cystitis trial are among the others."

Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace [Published Zecco - May 16 2013]

...Bob Uger, the Company's Chief Scientific Officer. "We are encouraged by our clinical experience to date with this drug, and believe we are setting the groundwork for a partner to move this program forward into Phase II testing."

Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients Wi ... [Published Stockwatch - May 16 2013]

More Content

sort by: Date \| Relevance
Big Data Unveils Exciting Head and Neck Cancer ... [Published Bioscience Technology Online - 3 hours ago]
Bionomics and CTx hit cancer treatment milestone [Published Australian Life Scientist - 19 hours ago]
Findings from A. Amsterdam and Co-Authors Provi... [Published NewsRX - May 17 2013]
Stem Cell Therapeutics to Begin Trading on the ... [Published Zecco - May 16 2013]
Stem Cell Therapeutics Announces Completion of ... [Published Stockwatch - May 16 2013]
Stem Cell Therapeutics Announces Completion of ... [Published PR inside - May 16 2013]
Two Curtis Transactions Honored at Internationa... [Published Curtis - May 16 2013]
Jack Green Joins Verastem as Chief Financial Of... [Published Business Wire - May 14 2013]
Verastem Posts First Quarter 2013 Financial and... [Published Individual.com - May 14 2013]
New Small Interference RNAs (siRNAs) Findings f... [Published NewsRX - May 10 2013]
New Stem Cells Study Findings Have Been Reporte... [Published NewsRX - May 10 2013]
Fellowship honour for Professor Tessa Holyoake [Published University Of Glasgow - May 09 2013]
09.05 - Fellowship honour for Professor Tessa H... [Published MyScience - May 09 2013]
Verastem Reports First Quarter 2013 Financial a... [Published Street Insider - May 09 2013]
Verastem Reports First Quarter 2013 Financial a... [Published Yahoo! Finance - May 09 2013]
Verastem to Present at Upcoming Conferences [Published Reuters - May 08 2013]
Verastem to Present at Upcoming Conferences [Published Business Wire Health News - May 08 2013]
Research Innovation Fund awards first projects [Published National Health Executive - May 07 2013]
New Findings from Roswell Park Cancer Institute... [Published NewsRX - May 04 2013]
Friday Science Review: May 3, 2013 [Published The Cross-Border Biotech Blog - May 03 2013]
National Cancer Institute at Frederick Describe... [Published NewsRX - May 03 2013]
Post-IPO Strength Seen In Stemline Therapeutics [Published BioMedReports - May 02 2013]
Pulmonary Adenocarcinoma in Malignant Pleural E... [Published Elites TV - May 02 2013]
Assessment of potential anti-cancer stem cell a... [Published Cancer Cell International - May 01 2013]
Assessment of potential anti-cancer stem cell a... [Published 7thSpace - May 01 2013]
Ben Seewald: From Brain Tumour Patient to Cross... [Published Huffington Post Canada - Apr 30 2013]
Stem Cells For Metastasis Found In Blood Of Bre... [Published Insciences - Apr 30 2013]
Atomic Force Microscopy and Ballistic Intracell... [Published Azonano - Apr 29 2013]
Co-Owner of Fort Worth Chiropractic Clinic Beat... [Published OSIX News - Apr 28 2013]
Network of scientists report 'squishy' cells in... [Published Health Canal - Apr 27 2013]

Blogs

sort by: Date \| Relevance
Friday Science Review: May 3, 2013 [Published The Cross-Border Biotech Blog - May 03 2013] The use of oncolytic viruses is becoming an increasingly attractive avenue for the treatment of cancer, because these viruses are able to destroy tumor cells and also generate immune-responses directed at those same tumor cells. Using human viruses for ...
Why did Mirna Therapeutics choose miR-34 for yo... [Published Future of BioPharma - Apr 04 2013] Recently, we sat down with TIDES speaker Dr. David Brown, the Director of Discovery at Mirna Therapeutics. He discussed at length Mi-RNAs and pre-clinical development programming. Today's featured question is: Why did Mirna Therapeutics choose ...
Harper Government Announces New Personalized Me... [Published Genome Blog - Mar 26 2013] Latest projects will offer new hope for Canadian patients with debilitating diseasesMedia Release,Toronto, Ontario, March 26, 2013 -Canadians with debilitating diseases will soon benefit from new personalized approaches to treatment thanks to researchers ...
Results of the Genome Canada - CIHR Research Pr... [Published Genome Blog - Mar 26 2013] Genome Canada and the Canadian Institutes of Health Research (CIHR), in partnership with the Cancer Stem Cell Consortium , have announced the 17 successful projects resulting from the 2012 Large-Scale Applied Research Competition in Genomics ...

Press Releases

sort by: Date \| Relevance
Stem Cell Therapeutics Announces Completion of ... [Published PR inside - May 16 2013]
Jack Green Joins Verastem as Chief Financial Of... [Published Business Wire - May 14 2013]
Verastem to Present at Upcoming Conferences [Published Business Wire Health News - May 08 2013]
Stem Cell Therapeutics Licenses Exclusive Right... [Published Marketwire - Breaking News Releases - Apr 17 2013]
ImmunoCellular Therapeutics Announces Issuance ... [Published EON Health & Medicine - Mar 04 2013]